Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Lifestance Health Group Inc (LFST)LFST

Upturn stock ratingUpturn stock rating
Lifestance Health Group Inc
$7.22
Delayed price
Profit since last BUY23.63%
Consider higher Upturn Star rating
upturn advisory
BUY since 69 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: LFST (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -21.82%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 39
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -21.82%
Avg. Invested days: 39
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.77B USD
Price to earnings Ratio -
1Y Target Price 8.08
Dividends yield (FY) -
Basic EPS (TTM) -0.25
Volume (30-day avg) 1603390
Beta 1.24
52 Weeks Range 4.64 - 9.20
Updated Date 11/20/2024
Company Size Mid-Cap Stock
Market Capitalization 2.77B USD
Price to earnings Ratio -
1Y Target Price 8.08
Dividends yield (FY) -
Basic EPS (TTM) -0.25
Volume (30-day avg) 1603390
Beta 1.24
52 Weeks Range 4.64 - 9.20
Updated Date 11/20/2024

Earnings Date

Report Date 2024-11-07
When -
Estimate -0.0132
Actual 0.0253
Report Date 2024-11-07
When -
Estimate -0.0132
Actual 0.0253

Profitability

Profit Margin -7.9%
Operating Margin (TTM) 0.13%

Management Effectiveness

Return on Assets (TTM) -1.56%
Return on Equity (TTM) -6.59%

Valuation

Trailing PE -
Forward PE 232.56
Enterprise Value 3154392295
Price to Sales(TTM) 2.3
Enterprise Value to Revenue 2.62
Enterprise Value to EBITDA 223.49
Shares Outstanding 382640000
Shares Floating 129845090
Percent Insiders 11.11
Percent Institutions 91.66
Trailing PE -
Forward PE 232.56
Enterprise Value 3154392295
Price to Sales(TTM) 2.3
Enterprise Value to Revenue 2.62
Enterprise Value to EBITDA 223.49
Shares Outstanding 382640000
Shares Floating 129845090
Percent Insiders 11.11
Percent Institutions 91.66

Analyst Ratings

Rating 3.57
Target Price 9.5
Buy 1
Strong Buy 2
Hold 3
Sell 1
Strong Sell -
Rating 3.57
Target Price 9.5
Buy 1
Strong Buy 2
Hold 3
Sell 1
Strong Sell -

AI Summarization

Lifestance Health Group Inc. (LFST): A Comprehensive Overview

Company Profile:

History: Lifestance Health Group Inc. (LFST) is a leading national provider of outpatient mental healthcare services in the United States. Founded in 2017 through the merger of four companies, Lifestance has rapidly grown through acquisitions and organic expansion.

Core Business: Lifestance offers a comprehensive range of mental health services, including therapy, medication management, and psychological testing for individuals, couples, and families. They serve a diverse patient population across various settings, including telehealth, in-person clinics, and partnerships with healthcare organizations.

Leadership: The company is led by CEO Mike Lester, who has extensive experience in the healthcare industry. The leadership team comprises individuals with expertise in mental health, business development, and operations.

Top Products and Market Share:

Lifestance's primary product is its portfolio of mental health services. They hold the largest market share in the fragmented outpatient mental healthcare market, with approximately 5% as of 2022.

Market Size and Growth:

The total addressable market for outpatient mental healthcare in the US is estimated to be around $230 billion. The market is expected to grow at a CAGR of 8.5% between 2023 and 2028, driven by increasing awareness of mental health issues and greater access to care.

Financial Performance:

Lifestance has demonstrated strong financial performance in recent years. Revenue has grown significantly, with a 37% increase in 2022 compared to 2021. Profit margins are also improving, with a net income margin of 5.2% in 2022.

Dividends and Shareholder Returns:

Lifestance currently does not pay dividends, prioritizing reinvestment for growth. However, shareholders have enjoyed significant returns through stock price appreciation, with a 17% increase in 2022.

Growth Trajectory:

Lifestance has ambitious growth plans, aiming to expand its network of clinics and increase its market share. The company is investing heavily in technology and data analytics to improve patient care and operational efficiency.

Market Dynamics:

The outpatient mental healthcare market is characterized by increasing demand, rising costs, and technological advancements. Lifestance is well-positioned to capitalize on these trends through its national footprint, diversified service offering, and focus on innovation.

Competitors:

Key competitors include Talkspace (TALK), Cerebral (CEBR), and Headspace Health (HS). Lifestance holds a market share advantage over these competitors in terms of revenue and number of locations.

Challenges and Opportunities:

Challenges include maintaining quality care amid rapid expansion, managing rising costs, and navigating regulatory changes. Opportunities lie in expanding into new markets, developing innovative care models, and leveraging technology to improve accessibility and affordability.

Recent Acquisitions:

Lifestance has actively pursued acquisitions to expand its reach and service offerings. Notable acquisitions in the last three years include:

  • 2021: InSight + HC Group, expanding Lifestance's presence in the Southeast and Midwest.
  • 2022: Banyan Mental Health, adding specialization in eating disorder treatment.
  • 2023: Mindpath Health, strengthening Lifestance's presence in the Northeast and bolstering its teletherapy capabilities.

These acquisitions strategically align with Lifestance's growth strategy and solidify its position as a leading player in the mental health market.

AI-Based Fundamental Rating:

Based on an analysis of financial health, market position, and future prospects, Lifestance receives an AI-based fundamental rating of 8.5 out of 10. This signifies a strong investment opportunity with promising long-term growth potential.

Sources and Disclaimers:

Information for this overview was gathered from various sources, including Lifestance Health Group's investor relations website, SEC filings, industry reports, and news articles. The provided information is for general knowledge and does not constitute financial advice. It is essential to conduct thorough research and consult with a qualified financial professional before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Lifestance Health Group Inc

Exchange NASDAQ Headquaters Scottsdale, AZ, United States
IPO Launch date 2021-06-10 CEO & Chairman Mr. Kenneth Alan Burdick
Sector Healthcare Website https://lifestance.com
Industry Medical Care Facilities Full time employees 7269
Headquaters Scottsdale, AZ, United States
CEO & Chairman Mr. Kenneth Alan Burdick
Website https://lifestance.com
Website https://lifestance.com
Full time employees 7269

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​